Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site
Introduction. The trends in the modern pharmaceutical industry demonstrate the need for proper documentation of all stages of the life cycle of a medicinal product to ensure its quality and eliminate risks to patients. Therefore, documenting pharmaceutical development, as the first stage of this cyc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-02-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/866 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696197612142592 |
|---|---|
| author | I. E. Smekhova L. V. Shigarova V. D. Meteleva E. V. Flisyuk |
| author_facet | I. E. Smekhova L. V. Shigarova V. D. Meteleva E. V. Flisyuk |
| author_sort | I. E. Smekhova |
| collection | DOAJ |
| description | Introduction. The trends in the modern pharmaceutical industry demonstrate the need for proper documentation of all stages of the life cycle of a medicinal product to ensure its quality and eliminate risks to patients. Therefore, documenting pharmaceutical development, as the first stage of this cycle, is relevant. It will allow regulating technological processes, product quality indicators, as well as ensuring the integrity of the data received. It is advisable to document the pharmaceutical development taking into account the requirements established at the enterprise where the industrial production of this drug is planned.Aim. Development of documentation for pharmaceutical development within the pharmaceutical quality system of the enterprise. One of the objectives of the study was to analyze the document flow of the pharmaceutical quality system of the enterprise planning the production of suppositories for the proper development of documentation for the pharmaceutical development of a medicinal product in this dosage form.Materials and methods. During the research the following methods were used: content analysis; system analysis; sociological (survey method); SWOT analysis technology; systems approach.Results and discussion. In order to get acquainted with modern trends related to pharmaceutical development and pharmaceutical quality system, at the first stage, an analysis of the ICH (International Council on Harmonization) guidance document Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers was carried out. An important preparatory stage for the optimal documentation of a pharmaceutical development was the study of the document flow of the pharmaceutical quality system of an enterprise planning to produce two-component suppositories. For this purpose, in the course of the research, a questionnaire was developed containing questions related to the functioning of the quality system, documentation processes and production. The analysis of the received responses made it possible to obtain information on documenting the pharmaceutical development of medicinal products, as well as to identify the main trends associated with this process within the pharmaceutical quality system.Conclusion. The documentation of the pharmaceutical quality system of the enterprise planning the production of suppositories has been analyzed. The strengths and weaknesses of the documentation are identified, a number of proposals for improving the documentation system are highlighted. Based on the results obtained, proposals will be developed for the optimal documentation of pharmaceutical development and a set of documents for an enterprise planning to produce two-component suppositories will be formed. |
| format | Article |
| id | doaj-art-e1cfcbf1de4145ce8838e87edd6be2f7 |
| institution | DOAJ |
| issn | 2305-2066 2658-5049 |
| language | Russian |
| publishDate | 2021-02-01 |
| publisher | LLC Center of Pharmaceutical Analytics (LLC «CPHA») |
| record_format | Article |
| series | Разработка и регистрация лекарственных средств |
| spelling | doaj-art-e1cfcbf1de4145ce8838e87edd6be2f72025-08-20T03:19:32ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492021-02-0110114214710.33380/2305-2066-2021-10-1-142-147799Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the SiteI. E. Smekhova0L. V. Shigarova1V. D. Meteleva2E. V. Flisyuk3Saint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversitySaint-Petersburg State Chemical-Pharmaceutical UniversityIntroduction. The trends in the modern pharmaceutical industry demonstrate the need for proper documentation of all stages of the life cycle of a medicinal product to ensure its quality and eliminate risks to patients. Therefore, documenting pharmaceutical development, as the first stage of this cycle, is relevant. It will allow regulating technological processes, product quality indicators, as well as ensuring the integrity of the data received. It is advisable to document the pharmaceutical development taking into account the requirements established at the enterprise where the industrial production of this drug is planned.Aim. Development of documentation for pharmaceutical development within the pharmaceutical quality system of the enterprise. One of the objectives of the study was to analyze the document flow of the pharmaceutical quality system of the enterprise planning the production of suppositories for the proper development of documentation for the pharmaceutical development of a medicinal product in this dosage form.Materials and methods. During the research the following methods were used: content analysis; system analysis; sociological (survey method); SWOT analysis technology; systems approach.Results and discussion. In order to get acquainted with modern trends related to pharmaceutical development and pharmaceutical quality system, at the first stage, an analysis of the ICH (International Council on Harmonization) guidance document Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers was carried out. An important preparatory stage for the optimal documentation of a pharmaceutical development was the study of the document flow of the pharmaceutical quality system of an enterprise planning to produce two-component suppositories. For this purpose, in the course of the research, a questionnaire was developed containing questions related to the functioning of the quality system, documentation processes and production. The analysis of the received responses made it possible to obtain information on documenting the pharmaceutical development of medicinal products, as well as to identify the main trends associated with this process within the pharmaceutical quality system.Conclusion. The documentation of the pharmaceutical quality system of the enterprise planning the production of suppositories has been analyzed. The strengths and weaknesses of the documentation are identified, a number of proposals for improving the documentation system are highlighted. Based on the results obtained, proposals will be developed for the optimal documentation of pharmaceutical development and a set of documents for an enterprise planning to produce two-component suppositories will be formed.https://www.pharmjournal.ru/jour/article/view/866pharmaceutical developmentpharmaceutical quality systemdocumentationsuppositoriesgood manufacturing practices |
| spellingShingle | I. E. Smekhova L. V. Shigarova V. D. Meteleva E. V. Flisyuk Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site Разработка и регистрация лекарственных средств pharmaceutical development pharmaceutical quality system documentation suppositories good manufacturing practices |
| title | Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
| title_full | Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
| title_fullStr | Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
| title_full_unstemmed | Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
| title_short | Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site |
| title_sort | documentation of pharmaceutical development part 1 study of the documentation of the site |
| topic | pharmaceutical development pharmaceutical quality system documentation suppositories good manufacturing practices |
| url | https://www.pharmjournal.ru/jour/article/view/866 |
| work_keys_str_mv | AT iesmekhova documentationofpharmaceuticaldevelopmentpart1studyofthedocumentationofthesite AT lvshigarova documentationofpharmaceuticaldevelopmentpart1studyofthedocumentationofthesite AT vdmeteleva documentationofpharmaceuticaldevelopmentpart1studyofthedocumentationofthesite AT evflisyuk documentationofpharmaceuticaldevelopmentpart1studyofthedocumentationofthesite |